Macleods Pharmaceuticals Ltd

Production of pharmaceutical substances for medicines against COVID-19 will start in Belgorod. The production will be launched by September 2021.

09 June 2021

An Indian investor plans to develop pharmaceutical manufacturing in the Perm Territory.

28 January 2021

Today, Governor Evgeniy Savchenko, Extraordinary and Plenipotentiary Ambassador of India Pankaj Saran and Deputy Minister of Industry and Trade of the Russian Federation Sergey Tsyb opened the first plant that Indian investors built in Russia from scratch. Advance Pharma was established due to the support of the Embassy of India, Ministry of Industry and Trade and the Government of Belgorod Region.

“This is just the beginning, we have a lot of work to do,” said Yevgeny Savchenko. “This project is very important not only for the region but for Russia as a whole: it will manufacture unique products for treatment of tuberculosis, HIV, oncology, and a wide range of diseases.”

Advanced Pharmaceuticals, a member of Advanced Trading group of companies, acts as the investor. It has been operating in the Russian pharmaceutical market since 2003, being the official supplier of medicines of the Indian producer Macleods Pharmaceuticals Limited.


14 March 2018

The construction of Advance Pharmaceuticals factory in Belgorod for the production of drugs for the therapy of tuberculosis, HIV, hepatitis and other diseases should be completed in 2017. The Belgorod plant will be the first Russian production of the official supplier of drugs of Indian pharmaceutical company Macleods Pharmaceuticals - Advance Trading. The volume of investments in the project amounted to 1.5 billion rubles.

29 March 2017

India-based drugmaker, Macleods Pharmaceuticals, has announced an investment of $25 million in the construction of a plant for the production of anti-tuberculous drugs in Russia’s Belgorod region by 2016.

Sergey Mironov, Head of Advanced Trading, stated that the new plant will focus on the production of life-saving medicines, which are expected to be in high demand in the Russian market. At the initial stage the new plant will focus on the production of anti-tuberculosis medicines, while later the production range is expected to be expanded.

The new plant will create more than 160 new jobs at the initial stage. 

21 December 2012
25.0 mln
Jobs: 160
Belgorod region

Investor profile

Macleods Pharmaceuticals Ltd

Mumbai, India

T: +91 2266762800

Contact: Mr Sergey Mironov, Head of Advanced Trading, Russia

Macleods Pharmaceuticals is a vertically integrated drug company, founded in 1986. The company has anti-tuberculosis as a focused area of operation and supplies first line and second line anti-tuberculosis drugs.